Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13757023 | 0.92 | MAPT (0.53) | SLC6A3ALDH1A1NPC1KMT2AMAPT | |
| SCHEMBL13172626 | 0.92 | NPC1 (0.50) | SLC6A3ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL2761732 | 0.89 | SLC6A3 (0.48) | SLC6A3ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL4279296 | 0.86 | MAPT (0.57) | ALDH1A1NPC1MEN1KMT2AMAPT | |
| SCHEMBL2874789 | 0.86 | SLC6A3 (0.52) | SLC6A3ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL1345244 | 0.84 | KMT2A (0.56) | SLC6A3MEN1KMT2AMAPTGAA | |
| SCHEMBL1345434 | 0.84 | KMT2A (0.56) | SLC6A3MEN1KMT2AMAPTGAA | |
| SCHEMBL8593569 | 0.84 | MEN1 (0.59) | SLC6A3ALDH1A1NPC1MEN1KMT2A | |
| SCHEMBL427393 | 0.84 | KMT2A (0.56) | SLC6A3MEN1KMT2AMAPTGAA | |
| SCHEMBL2614715 | 0.84 | MEN1 (0.59) | SLC6A3ALDH1A1NPC1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118166445-B | Antibacterial deodorizing coffee carbon fiber fabric and preparation method thereof | 广东华阳内衣有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118166445-A | Antibacterial deodorizing coffee carbon fiber fabric and preparation method thereof | 广东华阳内衣有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117854801-A | Production process of non-woven fabric film-coated copper flat wire | 江苏东恒光电有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-111072550-A | Nilapari important intermediate and enzyme catalytic synthesis method thereof | 苏州凯瑞医药科技有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-118166445-B | Antibacterial deodorizing coffee carbon fiber fabric and preparation method thereof | 广东华阳内衣有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118166445-B | Antibacterial deodorizing coffee carbon fiber fabric and preparation method thereof | 广东华阳内衣有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118166445-A | Antibacterial deodorizing coffee carbon fiber fabric and preparation method thereof | 广东华阳内衣有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-118166445-A | Antibacterial deodorizing coffee carbon fiber fabric and preparation method thereof | 广东华阳内衣有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117854801-A | Production process of non-woven fabric film-coated copper flat wire | 江苏东恒光电有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117854801-A | Production process of non-woven fabric film-coated copper flat wire | 江苏东恒光电有限公司 | 2024-04-09 | — | — | CN | disclosed |
| EP-2776398-B1 | SUBSTITUTED PYRAZOLYL-BASED UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS | MEDIFRON DBT INC (KR) | 2020-09-02 | — | — | EP | disclosed |
| CN-111072550-A | Nilapari important intermediate and enzyme catalytic synthesis method thereof | 苏州凯瑞医药科技有限公司 | 2020-04-28 | — | — | CN | disclosed |
| EP-2061767-A1 | ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE | Sanofi-Aventis (FR) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008017381-A1 | ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE | SANOFI-AVENTIS (FR) | 2008-02-14 | — | — | WO | disclosed |
| WO-2008017381-A1 | ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE | SANOFI-AVENTIS (FR) | 2008-02-14 | — | — | WO | disclosed |
| US-7288566-B2 | N-hydroxyformamidine derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-10-30 | — | — | US | disclosed |
| US-7288566-B2 | N-hydroxyformamidine derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-10-30 | — | — | US | disclosed |
| CN-1293049-C | N-Hydroxyformamidine Derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2007-01-03 | — | — | CN | disclosed |
| US-20060004078-A1 | N-hydroxyformamidine derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2006-01-05 | — | — | US | disclosed |
| CN-1681775-A | N-hydroxyformamidine derivative | TAISHO PHARMACEUTICAL CO LTD (JP) | 2005-10-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004078-A1 | N-hydroxyformamidine derivatives | FLT4, FLT1, PGF | SLC6A3 1329/4885ALDH1A1 323/4885NPC1 3281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.